A ground-breaking research project to develop an antiviral drug for Covid-19 has been rolled out in the UAE.
The social initiative Sandooq Al Watan and the University of Sharjah signed research agreements to launch the project, according to a report posted on Twitter by the Abu Dhabi Media Office (ADMO).
Introduced under Sandooq Al Watan’s applied research and development programme (SWARD), the research project aims to design a dual-inhibitor antiviral drug to treat SARS-CoV2 (the Covid-19 virus) which would be able to block “major enzymes” required for viral infection.
The University of Sharjah and New York University- Abu Dhabi, will focus on developing solutions for detecting Covid-19 in patients through a rapid, simple, scalable, and cost-effective method.
To view the full article, visit the website: Khaleej